Home
News & Events
News
117
Results found
-
Presentation slides from the RSNN session at FIGON Dutch Medicines days now available
During the FIGON Dutch Medicines days, which were held on 27 and 28 September, the RSNN together with ZonMw and KNMP organized a successful session around the topic of regulatory readiness. -
Register now for the RSNN Annual workshop 2021
Please join us at the RSNN Annual workshop 2021 titled "Upstream regulatory convergence and downstream diverge: unequal access for patients". The event will take place in person at the Jaarbeurs Utrecht and will also be broadcasted live. -
New edition of Regulatory Science Magazine published
Recently a new edition of the online Regulatory Science Magazine was published by the Medicines Evaluation Board (MEB). -
Publication: Extension of Indication for Authorised Oncology Products in the European Union
A journal article on the topic of "Extension of Indication for Authorised Oncology Products in the European Union" was published last week in the Regulatory Science magazine frontiers in Medicine. -
RSNN Newsletter 9: September 2021
The ninth edition of the RSNN Newsletter has just been published. This edition features an interview with Peter Bertens (VIG), news and updates on past and upcoming events. -
Join the RSNN session on Regulatory Readiness at the FIGON Dutch Medicines Days
We gladly invite you to join us at the RSNN session during the FIGON Dutch Medicines Days (FIGON DMD), which will be held at the Stadsgehoorzaal in Leiden on 27 and 28 September (in person). The session organized by the RSNN together with Saco de Visser (ZonMW) and Martina Teichert (KNMP) is titled “Regulatory Readiness” and will take place on Monday 27 September at 15:00. -
Save the date: RSNN annual workshop 2021
Please save the date for the RSNN annual workshop 2021. This year's workshop will take place on 23 November from 13.30-18.30 at the Jaarbeurs in Utrecht (in person). -
RSNN interview series: Peter Bertens
The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. It also provides an opportunity to highlight some of the current topics in the Regulatory Science field. -
Thesis defense PhD candidate Renske ten Ham (UU): "Development, market authorization and market access of gene and cell-based therapies"
On 4 June 2021 at 2:15pm PhD candidate Renske ten Ham from Utrecht University will defend her thesis titled: "Development, market authorization and market access of gene and cell-based therapies". -
MEB publishes Science Policy 2020-2024
Last week the Medicines Evaluation Board (MEB) published its Science Policy 2020-2024 titled 'regulating with the knowledge of tomorrow' The policy document specifies the eight main themes the MEB will focus on in the coming years. -
DIA Europe 2021 RSNN Session: Regulatory Science Dialogue
During the virtual DIA Europe 2021 conference from the 15th till the 19th of March, the RSNN organised the session titled “Regulatory Science Dialogue”. More than 60 attendees joined the session. -
RSNN Expert Meeting Report - Regulatory challenges for non-biological complex drugs (NBCDs)
On 8 December 2020, RSNN organized an Expert Meeting titled: Regulatory challenges for non-biological complex drugs (NBCDs) -
RSNN workshop report now available
The full report of the inspiring online RSNN workshop 'Leveraging the value of collaboration - from regulatory science to regulatory innovation' which took place on 17 November 2020 is now available. -
Season's Greetings from RSNN
RSNN wishes you happy holidays and a healthy New Year! -
FIGON DMD Virtual Series RSNN webinar from 3 December now available on demand
The FIGON DMD virtual series webinar "Regulatory responsiveness to public health challenges" organized by RSNN on 3 December is now available as on demand video.